(Q46894988)

English

Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lopinavir/ritonavir

1 reference

based on heuristic

inferred from title

author name string

Kit N Simpson

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Walter J Jones

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Rukmini Rajagopalan

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Birgitta Dietz

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

publication date

1 January 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Clinical Drug Investigation

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

27

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

12

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

807-817

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary and subsequent coronary risk appraisal: new results from the Framingham study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment-related factors and highly active antiretroviral therapy adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardio- and cerebrovascular events in HIV-infected persons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virological rebound after suppression on highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-utility analysis of early thrombolytic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate Markers for Disease Progression in Treated HIV Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18020538

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200727120-00002

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/18020538

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46894988&oldid=2136932154"